Pharmaceutical - Markets & Marketing, Oncology

Filter

Popular Filters

1 to 25 of 151 results

England's cancer outcomes worse than rest of Europe: National Audit Office report

England's cancer outcomes worse than rest of Europe: National Audit Office report

16-01-2015

The UK’s National Audit Office has published a report, Progress in improving cancer services and outcomes…

Markets & MarketingOncologyPharmaceuticalPoliticsPricingResearchUK

Ariad partners with Angelini on Iclusing in Central/Eastern Europe

Ariad partners with Angelini on Iclusing in Central/Eastern Europe

31-12-2014

US specialty pharma firm Ariad Pharmaceuticals has granted Italian drugmaker Angelini exclusive rights…

AngeliniAriad PharmaceuticalsEastern EuropeIclusigLicensingMarkets & MarketingOncologyPharmaceutical

Global oncology market to hit $109 billion in 2020

Global oncology market to hit $109 billion in 2020

26-11-2014

Cancer, with a death toll exceeding that of AIDS (acquired immune deficiency syndrome), tuberculosis…

AvastinCelgene Corp.GlobalMarkets & MarketingMergers & AcquisitionsNovartisOncologyPharmaceuticalResearchRevlimidRoche

Predictive biomarkers could help costly cancer drugs secure market access

25-11-2014

Biomarker driven prescribing is likely to positively influence perceptions of oncology drugs for both…

EuropeMarkets & MarketingOncologyPharmaceuticalPricing

Acute myeloid leukemia treatment market will grow to $878.6 million by 2020

Acute myeloid leukemia treatment market will grow to $878.6 million by 2020

25-11-2014

The global acute myeloid leukemia therapeutics market is predicted to increase from $632.6 million in…

GlobalMarkets & MarketingmidostaurinOncologyPharmaceuticalquizartinib

Oncology specialists say UK's capacity crisis is impacting patient care

Oncology specialists say UK's capacity crisis is impacting patient care

21-11-2014

A survey carried out by Swiss drug major Roche has shown that frontline staff believe patient care is…

Markets & MarketingOncologyPharmaceuticalResearchRocheUK

European prescribing trends for mCR prostate cancer

20-11-2014

Johnson & Johnson/AstraZeneca’s Zytiga (abiraterone acetate) is the clear agent of choice for second-line…

Astellas PharmaAstraZenecaBayerDendreonFranceGermanyItalyJohnson & JohnsonMarkets & MarketingMedivationOncologyPharmaceuticalProvengeSpainUKXofigoXtandiZytiga

Global melanoma market set to reach $3.6 billion by 2020

12-11-2014

The global melanoma therapeutics market was valued at $1.3 billion in 2013 and will expand at a compound…

Bristol-Myers SquibbEuropeJapanKeytrudaMarkets & MarketingMerck & CoOncologyOpdivoPharmaceuticalUSAYervoy

Medivation and Astellas' Xtandi to be market-leader in prostate cancer by 2023

Medivation and Astellas' Xtandi to be market-leader in prostate cancer by 2023

31-10-2014

Xtandi (enzalutamide), produced by biopharma company Medivation and Japanese drug major Astellas Pharma…

AstellasDecision Resources GroupJohnson & JohnsonMarkets & MarketingMedivationOncologyPharmaceuticalXtandiZytiga

Roche could lose its dominant market share in breast cancer, says IMS report

Roche could lose its dominant market share in breast cancer, says IMS report

03-10-2014

Biosimilars and new generation agents will end the market dominance of established breast cancer drugs,…

AstraZenecaGlobalHerceptinMarkets & MarketingNovartisOncologyPharmaceuticalRochetamoxifen

Report: HER2-positive breast cancer market could treble in USA by 2023

Report: HER2-positive breast cancer market could treble in USA by 2023

02-10-2014

The US treatment market for human epidermal growth factor receptor type 2 (HER2)-positive breast cancer…

HerceptinMarkets & MarketingOncologyPharmaceuticalRocheUSA

Intas launches DoceAqualip in India

Intas launches DoceAqualip in India

30-09-2014

Indian drugmaker Intas Pharmaceuticals says it has successfully launched the world’s first DoceAqualip…

DoceAqualipdocetaxelIndiaIntas PharmaceuticalsMarkets & MarketingOncologyPharmaceutical

Japan’s non-Hodgkin lymphoma market to exceed $1 billion by 2020

Japan’s non-Hodgkin lymphoma market to exceed $1 billion by 2020

26-09-2014

The non-Hodgkin lymphoma (NHL) treatment market in the Asia-Pacific (APAC) countries of India, Australia,…

AdcetrisAustraliaChinaGazyvaroIndiaJapanMarkets & MarketingOncologyPharmaceuticalRocheTakeda Pharmaceutical

Chugai launches ALK inhibitor Alecensa in Japan

Chugai launches ALK inhibitor Alecensa in Japan

07-09-2014

Japanese drugmaker Chugai Pharmaceutical said on Friday that it has launched the ALK inhibitor Alecensa…

AlecensaalectinibChugai PharmaceuticalJapanMarkets & MarketingOncologyPharmaceuticalRoche

Colorectal cancer market will remain steady at $7.7 billion by 2023; report

29-08-2014

The market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023…

EuropeJapanMarkets & MarketingOncologyPharmaceuticalUSA

Strong growth forecast for glioblastoma multiforme therapeutics in Asia-Pacific

Strong growth forecast for glioblastoma multiforme therapeutics in Asia-Pacific

26-08-2014

The glioblastoma multiforme therapeutics market in the four Asia-Pacific markets of Australia, China,…

Asia-PacificAustraliaAvastinCelldex TherapeuticsChinaCotaraIndiaJapanMarkets & MarketingOncologyPeregrine PharmaceuticalsPharmaceuticalrindopepimutRoche

Turkish man pleads guilty to importing illegal cancer drugs into USA

Turkish man pleads guilty to importing illegal cancer drugs into USA

17-08-2014

Sabahaddin Akman, owner of the Istanbul, Turkey, firm Ozay Pharmaceuticals, has pleaded guilty to charges…

AvastinLegalMarkets & MarketingOncologyOzay PharmaceuticalsPharmaceuticalRituxanSabahaddin AkmanTurkeyUSA

Imatinib and sunitinib will continue to dominate patient share in GIST treatment

Imatinib and sunitinib will continue to dominate patient share in GIST treatment

11-08-2014

The treatment landscape of gastrointestinal stromal tumors (GIST) will not change dramatically through…

BayerGleevecGlivecMarkets & MarketingNovartisOncologyPfizerPharmaceuticalStivargaSutent

Sanofi partners with Emcure for oncology portfolio in India

Sanofi partners with Emcure for oncology portfolio in India

06-08-2014

French pharma major Sanofi’s Indian subsidiary said today that it has entered into a marketing and…

Emcure PharmaceuticalsFasturtecFludaraIndiaJevtanaMarkets & MarketingOncologyPharmaceuticalSanofiTaxotere

US and European orphan status for AbbVie’s glioblastoma candidate

US and European orphan status for AbbVie’s glioblastoma candidate

04-08-2014

Both the European Medicines Agency and the US Food and Drug Administration have granted orphan drug designation…

AbbVieABT-414Brain tumorEuropeGlioblastoma multiformeMarkets & MarketingOncologyPharmaceuticalRare diseasesRegulationUS Food and Drug AdministrationUSA

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

02-07-2014

The introduction of several new drugs will accelerate growth in the chronic lymphocytic leukemia treatment…

EuropeidelalisibImbruvicaMarkets & MarketingOncologyPharmaceuticalUSA

Cancer immunotherapy market set to grow to nearly $9 billion across major markets in 2022

Cancer immunotherapy market set to grow to nearly $9 billion across major markets in 2022

01-07-2014

The cancer immunotherapy market will experience considerable growth through 2022, increasing from $1.1…

AstraZenecaBristol-Myers SquibbEuropeJapanMarkets & MarketingMED14736Merck & ConivolumabOncologypembrolizumabPharmaceuticalResearchRocheUSAYervoy

1 to 25 of 151 results

Back to top